Press release
Bristol-Meyers Squibb Sued by 72 Plaintiffs Over Plavix Side Effects
Nadrick & Cohen, LLP reports that 72 plaintiffs have joined together in a Plavix side effects lawsuit filed against Bristol-Meyers Squibb.Los Angeles, CA, January 27, 2012 – Seventy-two plaintiffs from across the country have joined together in filing a Plavix side effects lawsuit against the drug’s maker, Bristol-Meyers Squibb. According to the Madison Record, the plaintiffs are seeking an unspecified amount of compensation for injuries they say were caused by the drug.
The lawsuit, filed in an Illinois circuit court, includes plaintiffs from a number of states, including Ohio, California, Louisiana, New York and Connecticut. The plaintiffs allege that Plavix caused heart attacks, strokes, internal bleeding and other serious complications. The lawsuit also claims that Bristol-Meyers and co-defendant Sanofi Aventis marketed the drug inappropriately and failed to adequately warn consumers of the potential dangers.
Plavix (clopidogrel) was first approved by the U.S. Food and Drug Administration in 1997 for the prevention of heart attack and stroke. The drug was touted as being more effective and safer in reducing the risk of cardiovascular complications compared to a daily aspirin regimen.
In 2010, the FDA issued a new black box warning label for Plavix, advising health care professionals and patients that the drug’s effectiveness may be reduced for patients with a specific genetic variant. A new study published in 2011 suggested that the genetic test may not be as significant as previously thought in determining the drug’s effectiveness.
Patients who experienced complications after taking Plavix are urged to complete a MedWatch form by visiting the Food and Drug Administration’s website. It is also recommended that you contact an experienced personal injury lawyer to discuss your rights.
Nadrich & Cohen LLP offers confidential, no-cost consultations to Plavix users who believe they were harmed by the drug. Help is available by calling the firm’s injury hotline at 1-800-722-0765 or by completing an online case evaluation form at www.personalinjurylawcal.com.
Nadrich & Cohen LLP is a national law firm with offices in Los Angeles, Sacramento, San Diego and other cities throughout California. The firm specializes in handling mass tort actions and representing individuals in cases involving pharmaceutical companies, medical device makers and other product manufacturers. The firm is committed to achieving the best outcome possible in every case and has recovered over $200 million in settlements on behalf of its clients.
In addition to handling Plavix side effects claims, Nadrich & Cohen, LLP investigates cases involving Accutane, Avandia, DePuy Hip Implants, Zimmer Hips, Wright Conserve Hips, Vaginal Mesh, Pradaxa, Stevens-Johnson Syndrome, Reflex Sympathy Dystrophy, Fen Phen and PPH, Depakote and Reglan. All cases are accepted on a contingency basis, meaning there is never a fee unless we recover a judgment on your behalf. The time you have to file an injury claim is limited, so it’s important that you act quickly to protect your rights.
Jennifer Poole
National Client Intake Coordinator
Nadrich & Cohen LLP
12100 Wilshire Blvd.
Suite 1250
Los Angeles, CA 90025
800-718-4658
info@personalinjurylawcal.com
www.personalinjurylawcal.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bristol-Meyers Squibb Sued by 72 Plaintiffs Over Plavix Side Effects here
News-ID: 208823 • Views: …
More Releases from Nadrich & Cohen LLP
Yaz Lawsuit Settlements Reach $142 Million
Nadrich & Cohen, LLP reports that Bayer is continuing to offer settlements to plaintiffs involved in federal Yaz side effects litigation.
Los Angeles, CA, April 27, 2012 – Nadrich & Cohen, LLP reports that German drug-maker Bayer AG has settled approximately 651 Yaz side effects lawsuits totaling $142 million. Earlier this month, it was reported that the drug-maker had reached settlements in approximately 500 cases filed by women who claimed…
Yaz, Yasmin to Get New Labels as FDA Warns of Blood Clot Risk
Nadrich & Cohen, LLP reports that Yaz and similar birth control pills are to receive updated warning labels advising patients of the risk for developing serious blood clots.
Los Angeles, CA, April 10, 2012 – National law firm Nadrich & Cohen, LLP has learned that the U.S. Food and Drug Administration has ordered Bayer to produce new warning labels for several of its oral contraceptives, including Yaz, Yasmin and Beyaz.…
FDA Schedules Advisory Panel Meeting to Discuss Metal Hip Safety
Nadrich & Cohen, LLP reports that the FDA has scheduled an advisory panel to discuss the safety of metal hip implants.
Los Angeles, CA, March 29, 2012 – National law firm Nadrich & Cohen, LLP has learned that the U.S. Food and Drug Administration has a scheduled an advisory panel meeting to discuss the safety of metal hip implants and all-metal hip resurfacing systems.
The two-day panel, which is expected…
Pradaxa Side Effects Lawsuits Filed in Federal Court
Nadrich & Cohen, LLP reports that three Pradaxa side effects lawsuits have been filed in federal courts across the country.
Los Angeles, CA, March 7, 2012 – National law firm Nadrich & Cohen, LLP has learned that three Pradaxa side effects lawsuits have been filed against Boehringer Ingelheim, the drug’s manufacturer. The cases were filed in federal district courts located in Tennessee, Kentucky and Louisiana and it’s believed they are the…
More Releases for Plavix
Clopidogrel Market Growth Drivers, Opportunities, Share Report And Forecast To 2 …
"The Business Research Company recently released a comprehensive report on the Global Clopidogrel Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of…
Myocardial Infarction Treatment Market 2034: Clinical Trials, FDA Approvals, Pre …
Myocardial Infarction Companies are Thrombologic ApS, Honya Medical Inc, Boehringer Ingelheim, KU Leuven, Pfizer, Mesoblast, Inc., Beijing Anzhen Hospital, TargeGen, GlaxoSmithKline, Stiftung Institut fuer Herzinfarktforschung, Novartis, Mitsubishi Tanabe Pharma Corporation, Bayer, KAI Pharmaceuticals, Rambam Health Care Campus, Quantum Genomics SA, Hoffmann-La Roche, Egetis Therapeutics, Stempeutics Research Pvt Ltd, Lantheus Medical Imaging, and others.
(Albany, USA) DelveInsight's "Myocardial Infarction Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the…
Myocardial Infarction Market size was USD 21.7 billion in 2023 to Grow in Coming …
The Myocardial Infarction Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Myocardial Infarction, historical and forecasted epidemiology as well as the Myocardial Infarction market trends in the 7MM.
DelveInsight's "Myocardial Infarction Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Myocardial Infarction, historical and forecasted epidemiology as well as the Myocardial Infarction market trends in the United States, EU4 (Germany, Spain, Italy,…
Clopidogrel Market Insights, Forecast, Growth, and Trends 2024-2033
"The new report published by The Business Research Company, titled Clopidogrel Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the clopidogrel market size has grown rapidly in recent years. It will grow from $10.76 billion in 2023 to $11.87…
Clopidogrel Market: Size, Share, Growth, Analysis, Key Players, Revenue, Growth
Clopidogrel Market
Clopidogrel, sold as the brandname Plavix among others, is an antiplatelet medication that is used to reduce the risk of heart disease and stroke in those at high risk. It is also used together with aspirin in heart attacks and following the placement of a coronary artery stent. It is taken by mouth.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-3A7271/Global_Clopidogrel_Market_Insights_and_Forecast_to_2028
Report Scope
The Clopidogrel market size, estimations, and forecasts are provided in terms of sales volume…
Pharma Plm Market Trend, Size, Share, Growth Rate, and Top Companies - Aras Corp …
Pharma Plm Market research report provides fundamental insights into emerging trends and future growth drivers. With the help of expert analysis, the Pharma Plm Market research provides critical insights for 2022-2029. This research includes market size, share, restraints, and challenges. It also includes vital information for the entire forecast period. This study is designed to assist decision-makers in developing cost-effective and long-term sustainable development strategies.
Request a Free PDF Sample of…